Search research articles
Contact Us
Filters
Showing results (491-500 of 497) with videos related to
Page
of 50
Sort By:
You have reached the last page of results.
This site can display upto 497 results.
American Journal of Cancer Research
|
February 14, 2025
Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer
Hiroshi Arakawa, Shuhei Komatsu, Jun Kiuchi, et al.
The British Journal of Surgery
|
February 20, 2024
Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma
Jun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Annals of Surgical Oncology
|
September 24, 2025
Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged ≥ 80 Years with Gastric Cancer after Curative Resection: A Multicenter Cohort Study
Shutaro Sumiyoshi, Takeshi Kubota, Hiroyuki Inoue, et al.
Medical Oncology (Northwood, London, England)
|
January 3, 2019
Skeletal muscle mass as a predictor of the response to neo-adjuvant chemotherapy in locally advanced esophageal cancer
Takayuki Ota, Takeshi Ishikawa, Yuki Endo, et al.
Anticancer Research
|
August 5, 2010
RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker
Minoru Nishio, Chouhei Sakakura, Tomoyuki Nagata, et al.
Surgery Today
|
January 27, 2026
No regional survival disparities following curative gastrectomy in patients aged over 80 years with gastric cancer. a multicenter retrospective study
Shutaro Sumiyoshi, Takeshi Kubota, Hiroyuki Inoue, et al.
Journal of Gastric Cancer
|
April 6, 2026
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study
Takuma Ohashi, Takeshi Kubota, Hayato Fukui, et al.
Page
of 50
Search research articles
Search
Showing results (491-500 of 497) with videos related to
Sort By:
Page
of 50
You have reached the last page of results.
This site can display upto 497 results.
American Journal of Cancer Research
|
February 14, 2025
Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer
Hiroshi Arakawa, Shuhei Komatsu, Jun Kiuchi, et al.
The British Journal of Surgery
|
February 20, 2024
Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma
Jun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Annals of Surgical Oncology
|
September 24, 2025
Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged ≥ 80 Years with Gastric Cancer after Curative Resection: A Multicenter Cohort Study
Shutaro Sumiyoshi, Takeshi Kubota, Hiroyuki Inoue, et al.
Medical Oncology (Northwood, London, England)
|
January 3, 2019
Skeletal muscle mass as a predictor of the response to neo-adjuvant chemotherapy in locally advanced esophageal cancer
Takayuki Ota, Takeshi Ishikawa, Yuki Endo, et al.
Anticancer Research
|
August 5, 2010
RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker
Minoru Nishio, Chouhei Sakakura, Tomoyuki Nagata, et al.
Surgery Today
|
January 27, 2026
No regional survival disparities following curative gastrectomy in patients aged over 80 years with gastric cancer. a multicenter retrospective study
Shutaro Sumiyoshi, Takeshi Kubota, Hiroyuki Inoue, et al.
Journal of Gastric Cancer
|
April 6, 2026
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study
Takuma Ohashi, Takeshi Kubota, Hayato Fukui, et al.
Page
of 50